Download - WHOCC
Download - WHOCC
Download - WHOCC
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
QC<br />
CARDIOVASCULAR SYSTEM<br />
QC01<br />
QC01A<br />
CARDIAC THERAPY<br />
CARDIAC GLYCOSIDES<br />
Plain and combined preparations containing cardiac glycosides, including<br />
standardized herbal extracts, are classified in this group.<br />
QC01AA<br />
Digitalis glycosides<br />
Combinations with diuretics are classified here<br />
QC01AB<br />
QC01AC<br />
QC01AX<br />
Scilla glycosides<br />
Strophantus glycosides<br />
Other cardiac glycosides<br />
QC01B<br />
ANTIARRHYTHMICS, CLASS I AND III<br />
Preparations used in the treatment of arrhythmias should be classified in this<br />
group. See also QC08 - Calcium channel blockers.<br />
As in the ATC system, agents are listed according to the Vaughan Williams<br />
classification of antiarrhythmics. The division of class I antiarrhythmics may<br />
vary, depending on the literature used. The 3rd ed. of Avery’s Drug Treatment<br />
(1987) and Drugs 31, 93 - 95, 1986 have been used as a basis for the ATC<br />
classification.<br />
Class II antiarrhytmics are assigned to group QC07 - Beta blocking agents, and<br />
class IV antiarrhythmics to QC08 - Calcium channel blockers.<br />
Combined preparations are classified at separate 5th levels using the<br />
corresponding 50-series codes or, if not available, using the 5th level code 99.<br />
47